EOLS Evolus, Inc.
Nasdaq · SEC CIK 1570562 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.84M 7 sales by 2 insiders
- Filings on record
- 146 since 2021-08-12, latest 2026-09-04 19:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| MOATAZEDI DAVID | See Remarks, Dir | — | $1.66M |
| Avelar Rui | See Remarks | — | $177.7K |
| Mitchell Tatjana | CFO | — | — |
| Stewart Brady | Dir | — | — |
| Malik Vikram | Dir | — | — |
| Parschauer Karah Herdman | Dir | — | — |
| White Albert G III | Dir | — | — |
| GILL DAVID N | Dir | — | — |
Transactions 158
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-04 19:04 | 2026-09-02 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $9.04 | -105.1K | 499.6K | -17% | -$950.0K | |
| 2026-03-20 | 2026-03-20 | EOLS | Avelar Rui | See Remarks | S - Sale | $4.75 | -3,119 | 427.4K | -0.7% | -$14.8K | |
| 2026-03-20 | 2026-03-20 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $4.75 | -13.7K | 604.7K | -2% | -$64.9K | |
| D | 2026-03-18 | 2026-03-17 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale+OE | $4.89 | -116.7K | 618.4K | -16% | -$570.8K |
| D | 2026-03-18 | 2026-03-16 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | M - OptEx | $0.00 | +67.5K | 735.1K | +10% | $0 |
| D | 2026-03-18 | 2026-03-17 | EOLS | Avelar Rui | See Remarks | S - Sale+OE | $4.89 | -30.0K | 430.5K | -7% | -$146.7K |
| D | 2026-03-18 | 2026-03-16 | EOLS | Avelar Rui | See Remarks | M - OptEx | $0.00 | +8,804 | 460.5K | +2% | $0 |
| 2026-02-19 | 2026-02-17 | EOLS | Malik Vikram | Dir | A - Grant | $0.00 | +45.6K | 321.1K | +17% | $0 | |
| 2026-02-19 | 2026-02-17 | EOLS | Parschauer Karah Herdman | Dir | A - Grant | $0.00 | +45.6K | 77.7K | +142% | $0 | |
| 2026-02-19 | 2026-02-17 | EOLS | GILL DAVID N | Dir | A - Grant | $0.00 | +45.6K | 86.9K | +110% | $0 | |
| D | 2026-02-19 | 2026-02-17 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +313.2K | 667.6K | +88% | $0 |
| D | 2026-02-19 | 2026-02-17 | EOLS | Mitchell Tatjana | CFO | A - Grant | $0.00 | +121.5K | 226.1K | +116% | $0 |
| 2026-02-19 | 2026-02-17 | EOLS | Stewart Brady | Dir | A - Grant | $0.00 | +45.6K | 134.2K | +51% | $0 | |
| 2026-02-19 | 2026-02-17 | EOLS | White Albert G III | Dir | A - Grant | $0.00 | +45.6K | 95.9K | +90% | $0 | |
| D | 2026-02-19 | 2026-02-17 | EOLS | Avelar Rui | See Remarks | A - Grant | $0.00 | +94.9K | 451.7K | +27% | $0 |
| 2025-12-29 | 2025-12-22 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $7.15 | -10.5K | 354.4K | -3% | -$75.4K | |
| 2025-12-29 | 2025-12-22 | EOLS | Avelar Rui | See Remarks | S - Sale | $7.15 | -2,261 | 356.8K | -0.6% | -$16.2K | |
| D | 2025-10-09 | 2025-09-08 | EOLS | Mitchell Tatjana | CFO | A - Grant | $0.00 | +104.6K | 104.6K | New | $0 |
| 2025-08-26 | 2025-08-22 | EOLS | Yamagishi-Dressler Tomoko | CMO | S - Sale | $7.51 | -5,722 | 89.9K | -6% | -$43.0K | |
| 2025-08-18 | 2025-08-15 | EOLS | Stewart Brady | Dir | P - Purchase | $6.82 | +30.0K | 88.6K | +51% | +$204.6K | |
| M | 2025-06-16 | 2025-06-13+ | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $10.03 | -127.9K | 381.5K | -25% | -$1.28M |
| 2025-06-10 | 2025-06-09 | EOLS | White Albert G III | Dir | P - Purchase | $9.45 | +20.0K | 50.4K | +66% | +$189.0K | |
| 2025-05-14 | 2025-05-13 | EOLS | Beaver Sandra | CFO | S - Sale | $10.02 | -6,494 | 167.1K | -4% | -$65.1K | |
| 2025-05-14 | 2025-05-12 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $9.87 | -15.8K | 492.8K | -3% | -$155.8K | |
| 2025-05-14 | 2025-05-12 | EOLS | Avelar Rui | See Remarks | S - Sale | $9.87 | -3,385 | 359.1K | -0.9% | -$33.4K | |
| 2025-03-28 | 2025-03-27 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $12.40 | -6,251 | 508.6K | -1% | -$77.5K | |
| 2025-03-20 | 2025-03-18 | EOLS | Avelar Rui | See Remarks | S - Sale | $13.26 | -27.9K | 362.5K | -7% | -$370.0K | |
| 2025-03-20 | 2025-03-18 | EOLS | Yamagishi-Dressler Tomoko | CMO | S - Sale | $13.26 | -4,536 | 95.7K | -5% | -$60.1K | |
| 2025-03-20 | 2025-03-18 | EOLS | Beaver Sandra | CFO | S - Sale | $13.26 | -8,996 | 173.6K | -5% | -$119.3K | |
| 2025-03-20 | 2025-03-18 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.26 | -103.4K | 514.9K | -17% | -$1.37M | |
| 2025-03-14 | 2025-03-12 | EOLS | Parschauer Karah Herdman | Dir | S - Sale | $12.99 | -12.9K | 32.2K | -29% | -$167.4K | |
| D | 2025-03-11 | 2025-03-07 | EOLS | GILL DAVID N | Dir | A - Grant | $0.00 | +7,364 | 41.3K | +22% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | White Albert G III | Dir | A - Grant | $0.00 | +7,364 | 30.4K | +32% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | Parschauer Karah Herdman | Dir | A - Grant | $0.00 | +7,364 | 45.1K | +20% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | BLANK SIMONE | Dir | A - Grant | $0.00 | +7,364 | 77.1K | +11% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | Yamagishi-Dressler Tomoko | CMO | A - Grant | $0.00 | +17.8K | 100.2K | +22% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | Malik Vikram | Dir | A - Grant | $0.00 | +7,364 | 253.9K | +3% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | Beaver Sandra | CFO | A - Grant | $0.00 | +35.7K | 182.6K | +24% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | Avelar Rui | See Remarks | A - Grant | $0.00 | +23.8K | 390.4K | +6% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +95.4K | 618.2K | +18% | $0 |
| D | 2025-03-11 | 2025-03-07 | EOLS | Stewart Brady | Dir | A - Grant | $0.00 | +7,364 | 58.6K | +14% | $0 |
| 2024-12-26 | 2024-12-23 | EOLS | Beaver Sandra | CFO | S - Sale | $10.85 | -1,586 | 146.9K | -1% | -$17.2K | |
| 2024-12-26 | 2024-12-23 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $10.85 | -10.5K | 522.8K | -2% | -$113.9K | |
| 2024-12-26 | 2024-12-23 | EOLS | Avelar Rui | See Remarks | S - Sale | $10.85 | -2,252 | 366.6K | -0.6% | -$24.4K | |
| 2024-09-06 | 2024-09-06 | EOLS | Beaver Sandra | CFO | S - Sale | $14.98 | -3,276 | 148.5K | -2% | -$49.1K | |
| 2024-09-04 | 2024-08-30 | EOLS | Yamagishi-Dressler Tomoko | CMO | S - Sale | $15.85 | -5,631 | 82.4K | -6% | -$89.3K | |
| 2024-07-03 | 2024-07-01 | EOLS | White Albert G III | Dir | A - Grant | $0.00 | +23.0K | 23.0K | New | $0 | |
| DM | 2024-06-06 | 2024-06-04+ | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale+OE | $12.74 | -471.4K | 533.3K | -47% | -$6.01M |
| DM | 2024-06-06 | 2024-06-05+ | EOLS | MOATAZEDI DAVID | See Remarks, Dir | M - OptEx | $6.43 | +331.2K | 688.6K | +93% | +$2.13M |
| 2024-06-05 | 2024-06-03 | EOLS | Malik Vikram | Dir | S - Sale | $12.96 | -7,500 | 246.5K | -3% | -$97.2K | |
| M | 2024-05-15 | 2024-05-13+ | EOLS | GILL DAVID N | Dir | S - Sale | $12.64 | -10.4K | 34.0K | -23% | -$131.0K |
| 2024-05-15 | 2024-05-13 | EOLS | Malik Vikram | Dir | S - Sale | $12.93 | -28.0K | 254.0K | -10% | -$362.0K | |
| 2024-05-14 | 2024-05-10 | EOLS | Beaver Sandra | CFO | S - Sale | $12.72 | -2,423 | 151.8K | -2% | -$30.8K | |
| 2024-05-14 | 2024-05-10 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $12.72 | -16.1K | 673.6K | -2% | -$204.2K | |
| 2024-05-14 | 2024-05-10 | EOLS | Avelar Rui | See Remarks | S - Sale | $12.72 | -3,441 | 368.8K | -0.9% | -$43.8K | |
| 2024-03-29 | 2024-03-27 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.86 | -6,236 | 689.6K | -0.9% | -$86.4K | |
| 2024-03-21 | 2024-03-19 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.92 | -96.6K | 695.9K | -12% | -$1.34M | |
| 2024-03-21 | 2024-03-19 | EOLS | Beaver Sandra | CFO | S - Sale | $13.92 | -5,672 | 154.2K | -4% | -$79.0K | |
| 2024-03-21 | 2024-03-19 | EOLS | Avelar Rui | See Remarks | S - Sale | $13.92 | -27.6K | 372.3K | -7% | -$384.2K | |
| 2024-02-23 | 2024-02-22 | EOLS | Beaver Sandra | CFO | S - Sale | $13.08 | -1,821 | 159.9K | -1% | -$23.8K | |
| 2024-02-23 | 2024-02-21 | EOLS | Beaver Sandra | CFO | A - Grant | $0.00 | +13.1K | 161.7K | +9% | $0 | |
| 2024-02-23 | 2024-02-21 | EOLS | Avelar Rui | See Remarks | A - Grant | $0.00 | +13.1K | 401.7K | +3% | $0 | |
| 2024-02-23 | 2024-02-22 | EOLS | Avelar Rui | See Remarks | S - Sale | $13.08 | -1,821 | 399.9K | -0.5% | -$23.8K | |
| 2024-02-23 | 2024-02-22 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.08 | -7,706 | 792.4K | -1.0% | -$100.8K | |
| 2024-02-23 | 2024-02-21 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +61.2K | 800.1K | +8% | $0 | |
| D | 2024-02-09 | 2024-02-07 | EOLS | Parschauer Karah Herdman | Dir | A - Grant | $0.00 | +6,464 | 37.7K | +21% | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +135.0K | 738.9K | +22% | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | GILL DAVID N | Dir | A - Grant | $0.00 | +6,464 | 44.3K | +17% | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | Beaver Sandra | CFO | A - Grant | $0.00 | +35.2K | 148.6K | +31% | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | Stewart Brady | Dir | A - Grant | $0.00 | +6,464 | 51.3K | +14% | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | Malik Vikram | Dir | A - Grant | $0.00 | +6,464 | 282.0K | +2% | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | Yamagishi-Dressler Tomoko | CMO | A - Grant | $0.00 | +24.6K | 24.6K | New | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | BLANK SIMONE | Dir | A - Grant | $0.00 | +6,464 | 69.7K | +10% | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | HAYMAN ROBERT | Dir | A - Grant | $0.00 | +6,464 | 54.9K | +13% | $0 |
| D | 2024-02-09 | 2024-02-07 | EOLS | Avelar Rui | See Remarks | A - Grant | $0.00 | +35.2K | 388.6K | +10% | $0 |
| 2024-02-02 | 2024-01-30 | EOLS | Parschauer Karah Herdman | Dir | S - Sale | $13.14 | -11.9K | 31.2K | -28% | -$156.8K | |
| M | 2023-12-08 | 2023-12-06+ | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $9.95 | -82.6K | 603.9K | -12% | -$822.7K |
| 2023-10-18 | 2023-10-16 | EOLS | Medytox Inc. | Former 10% Owner | S - Sale | $7.50 | -1.69M | 3.38M | -33% | -$12.68M | |
| 2023-09-08 | 2023-09-06 | EOLS | Beaver Sandra | CFO | S - Sale | $9.70 | -3,178 | 113.4K | -3% | -$30.8K | |
| D | 2023-08-23 | 2023-08-21 | EOLS | Yamagishi-Dressler Tomoko | CMO | A - Grant | $0.00 | +63.4K | 63.4K | New | $0 |
| 2023-08-16 | 2023-08-14 | EOLS | Beaver Sandra | CFO | A - Grant | $0.00 | +19.7K | 118.8K | +20% | $0 | |
| 2023-08-16 | 2023-08-16 | EOLS | Beaver Sandra | CFO | S - Sale | $10.27 | -2,211 | 116.5K | -2% | -$22.7K | |
| 2023-08-16 | 2023-08-14 | EOLS | Avelar Rui | See Remarks | A - Grant | $0.00 | +19.7K | 355.6K | +6% | $0 | |
| 2023-08-16 | 2023-08-16 | EOLS | Avelar Rui | See Remarks | S - Sale | $10.27 | -2,211 | 353.4K | -0.6% | -$22.7K | |
| 2023-08-16 | 2023-08-16 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $10.27 | -14.8K | 686.6K | -2% | -$151.8K | |
| 2023-08-16 | 2023-08-14 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +91.8K | 701.4K | +15% | $0 | |
| 2023-08-15 | 2023-08-11 | EOLS | Malik Vikram | Dir | J - Other | $0.00 | +23.0K | 100.6K | +30% | $0 | |
| 2023-08-15 | 2023-08-15 | EOLS | Malik Vikram | Dir | P - Purchase | $7.41 | +175.0K | 275.6K | +174% | +$1.30M | |
| I | 2023-08-15 | 2023-08-11 | EOLS | HAYMAN ROBERT | Dir | J - Other | $0.00 | +366 | 10.4K | +4% | $0 |
| 2023-08-15 | 2023-08-11 | EOLS | HAYMAN ROBERT | Dir | J - Other | $0.00 | +218 | 48.4K | +0.5% | $0 | |
| 2023-08-15 | 2023-08-11 | EOLS | BLANK SIMONE | Dir | J - Other | $0.00 | +109 | 63.3K | +0.2% | $0 | |
| I | 2023-08-15 | 2023-08-11 | EOLS | BLANK SIMONE | Dir | J - Other | $0.00 | +115.2K | 482.8K | +31% | $0 |
| 2023-03-29 | 2023-03-27 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $8.47 | -6,110 | 609.6K | -1.0% | -$51.8K | |
| 2023-03-16 | 2023-03-14 | EOLS | Avelar Rui | See Remarks | S - Sale | $8.47 | -14.9K | 335.9K | -4% | -$126.3K | |
| 2023-03-16 | 2023-03-14 | EOLS | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $8.47 | -64.2K | 615.7K | -9% | -$543.9K | |
| 2023-02-22 | 2023-02-17 | EOLS | Alphaeon 1 LLC | 10% | S - Sale | $8.40 | -1.85M | 4.21M | -31% | -$15.54M | |
| 2023-02-08 | 2023-02-07 | EOLS | Medytox Inc. | 10% | S - Sale | $8.50 | -2.19M | 5.07M | -30% | -$18.59M | |
| MI | 2023-02-06 | 2021-08-12+ | EOLS | Medytox Inc. | 10% | P - Purchase | $11.04 | +37.0K | 7.30M | +0.5% | +$408.8K |
| I | 2023-02-06 | 2023-01-20 | EOLS | Medytox Inc. | 10% | S - Sale | $11.04 | -37.0K | 7.26M | -0.5% | -$409.0K |
| D | 2023-01-31 | 2023-01-27 | EOLS | BLANK SIMONE | Dir | A - Grant | $0.00 | +8,293 | 63.2K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations